Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2020

Jun 23, 2020

30870_dirs_2020-06-23_6c972ec9-879f-4465-a12f-fbfb9a045db3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-06-22

Reporting Person: PARSHALL B LYNNE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-22 Common Stock M 10000 $4.44 Acquired 10000 Direct
2020-06-22 Common Stock S 10000 $25.0 Disposed 0 Direct
2020-06-22 Common Stock M 6510 $6.72 Acquired 6510 Direct
2020-06-22 Common Stock S 6510 $25.0 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-22 Non-Qualified Stock Option (right to buy) $4.44 M 10000 Disposed 2024-05-21 Common Stock (10000) Direct
2020-06-22 Non-Qualified Stock Option (right to buy) $6.72 M 6510 Disposed 2024-01-02 Common Stock (6510) Direct